Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 2 |
2008 | 1 |
2009 | 1 |
2010 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
A new fork for clinical application: targeting forkhead transcription factors in cancer.
Clin Cancer Res. 2009 Feb 1;15(3):752-7. doi: 10.1158/1078-0432.CCR-08-0124.
Clin Cancer Res. 2009.
PMID: 19188143
Free PMC article.
Review.
Deciphering the role of forkhead transcription factors in cancer therapy.
Yang JY, Hung MC.
Yang JY, et al.
Curr Drug Targets. 2011 Aug;12(9):1284-90. doi: 10.2174/138945011796150299.
Curr Drug Targets. 2011.
PMID: 21443462
Free PMC article.
Review.
Item in Clipboard
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.
Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, Huang H, Kuo HP, Lee DF, Li LY, Lien HC, Cheng X, Chang KJ, Hsiao CD, Tsai FJ, Tsai CH, Sahin AA, Muller WJ, Mills GB, Yu D, Hortobagyi GN, Hung MC.
Yang JY, et al.
Nat Cell Biol. 2008 Feb;10(2):138-48. doi: 10.1038/ncb1676. Epub 2008 Jan 20.
Nat Cell Biol. 2008.
PMID: 18204439
Free PMC article.
Item in Clipboard
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation.
Yang JY, Zong CS, Xia W, Wei Y, Ali-Seyed M, Li Z, Broglio K, Berry DA, Hung MC.
Yang JY, et al.
Mol Cell Biol. 2006 Oct;26(19):7269-82. doi: 10.1128/MCB.00172-06.
Mol Cell Biol. 2006.
PMID: 16980628
Free PMC article.
Item in Clipboard
Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
Tan M, Lan KH, Yao J, Lu CH, Sun M, Neal CL, Lu J, Yu D.
Tan M, et al.
Cancer Res. 2006 Apr 1;66(7):3764-72. doi: 10.1158/0008-5472.CAN-05-2747.
Cancer Res. 2006.
PMID: 16585203
Item in Clipboard
Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
Yang JY, Chang CJ, Xia W, Wang Y, Wong KK, Engelman JA, Du Y, Andreeff M, Hortobagyi GN, Hung MC.
Yang JY, et al.
Cancer Res. 2010 Jun 1;70(11):4709-18. doi: 10.1158/0008-5472.CAN-09-4524. Epub 2010 May 18.
Cancer Res. 2010.
PMID: 20484037
Free PMC article.
Item in Clipboard
Cite
Cite